HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Conventional therapy with an ACE inhibitor diminishes left ventricular dyssynchrony during the progression of heart failure.

AbstractPURPOSE:
Left ventricular (LV) mechanical dyssynchrony is an important codeterminant of cardiac dysfunction in heart failure (HF) patients exhibiting either a narrow or a wide QRS complex. We hypothesized that an angiotensin converting enzyme (ACE) inhibitor would prevent LV dyssynchrony during the progression of pacing-induced HF through its beneficial effects on hemodynamic change and myocardial fibrosis.
METHODS:
Twenty-eight dogs were assigned to the following treatment groups; rapid ventricular pacing (HF group; n=10), concomitant ACE inhibitor and rapid pacing (enalapril 1.9 mg/kg/day: ACEI group; n=8), or sham-operated control (control group; n=10). After 4 weeks of pacing, cardiac function was evaluated using micromanometers and conductance catheters. We used indexes to quantify the temporal and spatial aspects of mechanical dyssynchrony derived from online segmental conductance catheter signals. At each time point, a segmental signal was defined as dyssynchronous if its change was opposite to the simultaneous change in the total LV volume. Mechanical dyssynchrony was calculated as the mean of the segmental dyssynchronies during systole, diastole, and throughout the cardiac cycle.
RESULTS:
In the ACEI group, the LV ejection fraction was preserved, and total systemic resistance and end-diastolic volume were significantly decreased, while stroke volume was significantly increased compared to the HF group. The mechanical dyssynchrony index in the HF group was significantly higher compared to that of the control group, while it was significantly lower in the ACEI group. Thus, conventional therapy with an ACE inhibitor diminished LV dyssynchrony during the progression of pacing-induced HF.
AuthorsTairo Kurita, Katsuya Onishi, Kaoru Dohi, Takeshi Takamura, Naoki Fujimoto, Takashi Tanigawa, Kyoko Imanaka-Yoshida, Hideo Wada, Tsutomu Nobori, Masaaki Ito
JournalInternational journal of cardiology (Int J Cardiol) Vol. 140 Issue 1 Pg. 48-54 (Apr 01 2010) ISSN: 1874-1754 [Electronic] Netherlands
PMID19068269 (Publication Type: Journal Article)
CopyrightCopyright 2008 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Angiotensin-Converting Enzyme Inhibitors
  • Angiotensin II
  • Aldosterone
  • Norepinephrine
Topics
  • Aldosterone (blood)
  • Angiotensin II (blood)
  • Angiotensin-Converting Enzyme Inhibitors (pharmacology, therapeutic use)
  • Animals
  • Comorbidity
  • Disease Progression
  • Dogs
  • Heart Failure (epidemiology, physiopathology)
  • Hemodynamics
  • Male
  • Norepinephrine (blood)
  • Ventricular Dysfunction, Left (epidemiology, physiopathology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: